MALCOLM BERGER
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology BRACKENRIDGE, PA NPI 1073577243
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology PA GENZYME CORPORATION All categories
General Payments — all program years on this page
$14,844.99
- Category: General Payments
- Program years: PY2018–2023
- Record count: 123
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $1,076.94 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,076.94 | 9 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $618.12 | 5 |
| ACADIA Pharmaceuticals Inc | $228.60 | 2 |
| Lundbeck LLC | $115.47 | 1 |
| ABBVIE INC. | $114.75 | 1 |
By program year
Records — PY2023 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1032178345 | Lundbeck LLC | $115.47 | 10/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1050315495 | GENZYME CORPORATION | $117.93 | 06/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1050315547 | GENZYME CORPORATION | $133.35 | 07/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1050315551 | GENZYME CORPORATION | $108.34 | 05/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1050315559 | GENZYME CORPORATION | $119.79 | 08/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1050315623 | GENZYME CORPORATION | $138.71 | 10/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1053118381 | ACADIA Pharmaceuticals Inc | $114.30 | 11/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1053118385 | ACADIA Pharmaceuticals Inc | $114.30 | 11/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 996241819 | AbbVie Inc. | $114.75 | 08/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.